RxDoctor Payments Data

Ashley McDowell, PA

Physician Assistant · Las Vegas, NVNPI 1053733345

Payments from drug & device makers

$1,431in general payments, 2019–2025

Across 83 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$203
  • Novo Nordisk$202
  • AstraZeneca$188
  • Boehringer Ingelheim$151
  • Johnson & Johnson$130
  • GSK$125
  • plus $431 from 9 others

What the payments were for

  • Food & beverage$1,431100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,431 in reported general payments places this provider in the 70th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada

Medicare billing

Part B allowed, 2024
$4,367
Medicare patients
24
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban29$52,366
JardianceEmpagliflozin11$19,823
OzempicSemaglutide11$14,368
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$13,978
Albuterol Sulfate HfaAlbuterol Sulfate59$2,104
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen88$1,282
Losartan Potassium116$1,250
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,233
Atorvastatin Calcium133$1,144
Rosuvastatin Calcium113$1,061
Levothyroxine Sodium144$1,012
ValacyclovirValacyclovir Hcl21$978
Fluticasone Propionate66$977
Gabapentin56$844
Amlodipine Besylate117$810

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$106$52,36629 claims
Boehringer IngelheimJardiance$151$19,82311 claims
Novo NordiskOzempic$202$14,36811 claims
GSKTrelegy Ellipta$125$13,97813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 881 physician assistant providers in Nevada.

Other physician assistant in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →